FOX8 Cleveland

Baebies Receives FDA 510(k) Clearance for G6PD Test on FINDER Platform

DURHAM, N.C., Nov. 9, 2022 /PRNewswire/ -- Baebies has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its rapid, point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) ...
Business Wire

MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment with Chloroquine and Hydroxychloroquine

-Accurate, Plug and Play Test Measures G6PD Activity in Whole Blood, Detecting Both Presence and Severity of G6PD Deficiency, Providing Key Insight to Inform Drug Therapy Options CANTON, ...
technologynetworks

MedTest Dx Manufacturing FDA Approved Quantitative Test for G6PD for COVID-19 Treatment

MedTest Dx, Inc., an established solution provider for clinical diagnostic testing, is providing a critical tool in the fight against COVID-19 with its Pointe Scientific-branded assay for the highly ...
Nature

Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common X-linked enzymopathy can lead to severe hyperbilirubinemia, acute bilirubin encephalopathy and kernicterus in the United States. Neonatal ...